GO
| HSI1 | 24,963.23 | -247.58 | 209.88B |
| HSCEI1 | 8,271.06 | -81.61 | 65.42B |
| Back Zoom + Zoom - Block Traded | |
|
2026-07-24 15:09:32 JPMorgan published a research report initiating coverage on two Chinese Artificial Intelligence Drug Discovery (AIDD) companies, INSILICO (03696.HK) and XTALPI (02228.HK), both with Overweight ratings. JPMorgan said China's AIDD industry is transitioning from the commercial exploration stage to early commercialization, driven by increasing BD activities and clinical catalysts. The broker was bullish on China's AIDD sector and expected the industry to hail valuation re-rating opportunities. The broker favored INSILICO's high-risk, high-return pipeline built through AIDD, while also viewing positively XTALPI's diversified business centered on AIDD services and robotic wet laboratories. The broker set TP at HKD71 and HKD10 for INSILICO and XTALPI, respectively. ~ AASTOCKS Financial News Website: www.aastocks.com | |